Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,223 public trials 1,013 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

A Study to Test Different Doses of BI 836880 Combined With Ezabenlimab in Patients With Advanced Non-small Cell Lung Cancer Followed by Other Types of Advanced Solid Tumours

NCT03468426

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • Winship Cancer Institute Atlanta, Georgia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 43 locations
View Trial Details
Completed

Study of Boserolimab (MK-5890) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Adults With Advanced Solid Tumors (MK-5890-001)

NCT03396445

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +15 more
Locations
  • University of South Alabama, Mitchell Cancer Institute ( Site 0020) Mobile, Alabama, United States
  • Florida Cancer Specialists ( Site 0002) Sarasota, Florida, United States
  • The West Clinic, P.C. ( Site 0021) Germantown, Tennessee, United States
  • FALP-UIDO ( Site 0502) Santiago, Region M. de Santiago, Chile
View all 18 locations
View Trial Details
Completed

A Study of Lorlatinib in ALK Inhibitor-Treated ALK-Positive NSCLC in China

NCT03909971

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Gaoxin Hospital of The First Affilated Hospital of Anhui Medical University Hefei, Anhui, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Province Oncology Hospital Fuzhou, Fujian, China
  • Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
View all 21 locations
View Trial Details
Completed

Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).

NCT02831959

Conditions
Brain Diseases, Brain Metastases From Non-small Cell Lung Cancer (NSCLC), Brain Neoplasms, +14 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Grandview Medical Center - Cancer Center Birmingham, Alabama, United States
  • Infirmary Cancer Care Mobile, Alabama, United States
  • Barrow Neurological Institute Phoenix, Arizona, United States
View all 128 locations
View Trial Details
Completed

An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)

NCT02477826

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Southern Cancer Center, Inc. Mobile, Alabama, United States
  • Local Institution - 0017 San Francisco, California, United States
  • Local Institution - 0021 New Haven, Connecticut, United States
  • Local Institution - 0001 Atlanta, Georgia, United States
View all 290 locations
View Trial Details
Completed

Study of DF9001 in Patients With Advanced Solid Tumors

NCT05597839

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +25 more
Locations
  • Banner MD Anderson Gilbert, Arizona, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • UC Irvine Medical Center Irvine, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 17 locations
View Trial Details

Related conditions